ENDPOINTS

Bristol Myers' MyoKardia unit ends work with Fulcrum; ALX discloses layoffs

Plus, news about Tenax Therapeutics and Celon Pharma: Fulcrum Therapeutics loses a partner: Bristol Myers Squibb’s MyoKardia unit told Fulcrum last week that it is terminating a

Mar 5, 2025 - 16:15
 0
Bristol Myers' MyoKardia unit ends work with Fulcrum; ALX discloses layoffs
Plus, news about Tenax Therapeutics and Celon Pharma: Fulcrum Therapeutics loses a partner: Bristol Myers Squibb’s MyoKardia unit told Fulcrum last week that it is terminating a
Read More

Tags:

Previous Article

Hyundai IONIQ 9 Is Going To Be A Hit Among Rich Families (Not Notable Volumes, B...

Next Article

Healthcare’s Workforce Blueprint is Out Of Date. It’s Time For A Change

Related Posts

Alnylam eyes bigger diseases in more tissue types at ‘inflection point’ for siRNA

Alnylam eyes bigger diseases in more tissue types at ‘i...

Feb 25, 2025  0

Hansoh ends collaboration with Silence; Vir hunts for HBV drug partner

Hansoh ends collaboration with Silence; Vir hunts for H...

Feb 27, 2025  0

Teva launches Stelara biosimilar at 85% discount as wider field emerges

Teva launches Stelara biosimilar at 85% discount as wid...

Feb 21, 2025  0